Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > Halt it halt it halt it !!!!!!

<< Previous

Bullboard Posts

Next >>

Comment by SEEdgaron Jul 13, 2018 12:31pm

99 Views

Post# 28312854

RE:Halt it halt it halt it !!!!!!

at this point in the day I rather it play out, monday before open halt with news late afternoon re opening tuesday morning. From going through the news reports and down through tjis board( had to ignore alot of people to get to good value info lol) This company is ready to pop again the chart looks awesome like promis and antibe did earlier this year

<< Previous

Bullboard Posts

Next >>

Canadian government to fund Electric Royalties portfolio property